Sandoz Group (OTCMKTS:SDZNY) Trading Up 3.3% – What’s Next?

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY) rose 3.3% during trading on Friday . The company traded as high as $76.84 and last traded at $76.84. Approximately 2,413 shares traded hands during trading, a decline of 92% from the average daily volume of 29,782 shares. The stock had previously closed at $74.40.

Wall Street Analysts Forecast Growth

Separately, Barclays upgraded Sandoz Group to a “strong-buy” rating in a research note on Monday, October 13th. One equities research analyst has rated the stock with a Strong Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy”.

Sandoz Group Price Performance

The company has a debt-to-equity ratio of 0.62, a current ratio of 1.29 and a quick ratio of 0.82. The stock has a fifty day moving average price of $69.01 and a 200 day moving average price of $62.01.

About Sandoz Group

Sandoz Group (OTCMKTS:SDZNY) is a multinational pharmaceutical company focused on the development, manufacturing and commercialization of generic medicines and biosimilars. The company supplies off-patent small-molecule drugs as well as biologic alternatives intended to offer lower-cost therapeutic options across a range of clinical areas. Sandoz emphasizes access and affordability, positioning its portfolio to serve hospitals, pharmacies and health systems looking to expand patient access to essential therapies.

The company’s product offerings span conventional generics, complex and specialty generics, and a growing pipeline of biosimilar medicines.